Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Biocryst Pharmaceuticals Inc (NASDAQ: BCRX) closed the day trading at $7.52 down -0.13% from the previous closing price of $7.53. In other words, the price has decreased by -$0.13 from its previous closing price. On the day, 1.51 million shares were traded. BCRX stock price reached its highest trading level at $7.7 during the session, while it also had its lowest trading level at $7.455.
Ratios:
For a better understanding of BCRX, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.73 and its Current Ratio is at 2.78.
On September 18, 2023, RBC Capital Mkts Upgraded its rating to Outperform which previously was Sector Perform and also upped its target price recommendation from $9 to $10.
Jefferies Upgraded its Hold to Buy on August 04, 2023, while the target price for the stock was maintained at $11.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Dec 13 ’24 when Hutson Nancy J sold 7,000 shares for $7.54 per share. The transaction valued at 52,780 led to the insider holds 86,638 shares of the business.
Hutson Nancy J bought 7,000 shares of BCRX for $52,584 on Dec 13 ’24. On Jun 24 ’24, another insider, McKee Amy E, who serves as the Director of the company, sold 8,600 shares for $6.32 each. As a result, the insider received 54,352 and left with 27,831 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BCRX now has a Market Capitalization of 1557640064 and an Enterprise Value of 2069761920. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.77. Its current Enterprise Value per Revenue stands at 5.017 whereas that against EBITDA is -64.8.
Stock Price History:
Over the past 52 weeks, BCRX has reached a high of $8.88, while it has fallen to a 52-week low of $4.03. The 50-Day Moving Average of the stock is -1.58%, while the 200-Day Moving Average is calculated to be 10.06%.
Shares Statistics:
Over the past 3-months, BCRX traded about 1.96M shares per day on average, while over the past 10 days, BCRX traded about 1846800 shares per day. A total of 207.12M shares are outstanding, with a floating share count of 188.26M. Insiders hold about 9.11% of the company’s shares, while institutions hold 78.73% stake in the company. Shares short for BCRX as of 1734048000 were 17286947 with a Short Ratio of 8.81, compared to 1731628800 on 18488541. Therefore, it implies a Short% of Shares Outstanding of 17286947 and a Short% of Float of 8.41.
